Novosanis

On-demand Satellite Symposium

Stephanie Jordaens
"Urine as promising biomarker source for cancer detection"

Watch the symposium now

About Novosanis

Novosanis is a subsidiary of OraSure Technologies, Inc. Novosanis prospers in user-friendly and game-changing medical devices meeting all regulatory and quality requirements for self-sampling solutions, which improves accuracy and standardization while making handling easier, more consistent and more comfortable for the user.

Colli-Pee®, the heart of the company, allows volumetric and standardized first-void urine collection. The platform consists of variants capturing a range of urine volumes for different application purposes.

To know more about Novosanis and the journey of Colli-Pee visit https://novosanis.com/about-us

Why use first-void urine

Urine fractions are not the same. First-void urine, generally termed the first 5mL to 50mL of urine flow, contains higher concentrations of STI-related DNA than other fractions – for example, first-void urine contains more Human Papillomavirus (HPV) DNA than subsequent fractions. Strains of HPV are a major cause of cervical cancer. Additionally, first-void urine is important to identify prostate cancer biomarkers.

To know more about the potential of urine and its oncology applications visit https://novosanis.com/oncology

Why use Colli-Pee®

Collecting a first-void urine sample with a standard urine cup can be awkward, messy and inconvenient for the user.

For this reason, Novosanis developed Colli-Pee®, a device that can be used by both men and women. Colli-Pee® allows for standardized, volumetric collection of the first fraction of urine. The device architecture also enables immediate mixing of urine and preservative for adequate stability.

To know more about the Colli-Pee device visit https://novosanis.com/our-products

Video

Resources

• Coll-Pee® spec sheet
• White paper - Urine as a liquid biopsy
• White paper - Urine as an emerging liquid biopsy for prostate cancer biomarkers
• White paper - Why urine preservation is needed for molecular cancer biomarker detection

Any questions? Contact:

Stephanie Jordaens
Biomedical Scientist, PhD Student
stephanie.jordaens@novosanis.com

David Faster
Sr Product Manager
david.faster@novosanis.com 
 

Live chat

If you see a 'Let's chat' icon on the bottom right of the page, it means that a representative is online and ready to chat and answer your questions! Click on the icon to chat with them.

If you see a 'Send message' button it means nobody is online right now, but you can send an email instead.